Skip to content

XTI Aerospace, Inc. XTIA Warrant Issuance Expenses

Warrant Issuance Expenses at other companies

Precigen logo
PrecigenPGEN
$0-100%
Evommune
 logo
Evommune EVMN
$150
Evommune
 logo
Evommune EVMN
$150
Opus Genetics logo
Opus GeneticsIRD
$0-100%
Blaize Holdings, Inc. Common Stock logo
Blaize Holdings, Inc. Common StockBZAI
$268.25K
NovaGold Resources logo
NovaGold ResourcesNG
$0-100%

Other financials

Income statement

See full
Revenue$27.7M+5,622%
Gross profit$5.1M+1,436%
Operating income-$10.4M-26.7%
Net income-$35.3M-174%
EPS (diluted)-$1.00+73.7%

Balance sheet

See full
Cash & equivalents$15.2M+89.6%
Total debt$22.8M+14,541%
Total equity-$26.6M-291%
Total assets$78.3M+189%

Cash flow

See full
Operating cash flow-$10.5M+31.4%
CapEx$131.0K+191%
Free cash flow-$10.6M+30.8%

Valuation

See full
Market cap$69.64M+136%
Enterprise value$77.3M+970%
P/S1.4×-8.3×

Profitability

See full
Gross margin19.6%-40.5pp
Operating margin-86.1%-40.7pp
Net margin-183.4%-84.9pp
FCF margin-64.6%-31.3pp

Returns & leverage

See full
Return on equity-565.7%
Debt / equity1.1×+0.6×
Current ratio0.6×-0.4×

Where this comes from

Reported directly by XTI Aerospace, Inc. in its filing.

Tagged under the XBRL concept xtia:WarrantIssuanceExpenses.

The official record: XTI Aerospace, Inc.’s 10-K, filed April 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about XTI Aerospace, Inc.'s warrant issuance expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XTI Aerospace, Inc.'s warrant issuance expenses?
XTI Aerospace, Inc. (XTIA) reported warrant issuance expenses of $0 in Q4 2025.
What does warrant issuance expenses mean?
Captures the direct costs, such as legal, accounting, and underwriting fees, associated with the issuance of warrants to investors. These expenses are typically recognized as a reduction in cash flow from operations or as a financing cost depending on accounting treatment. High levels of these expenses may indicate significant capital raising activity or complex equity structuring.